Validation of death certificate diagnosis for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC)

S A Coady1, P D Sorlie, L S Cooper

  • 1Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, II Rockledge Center, 6701 Rockledge Drive MSC 7934, Bethesda, MD 20982, USA.

Insights

The death certificate overestimates coronary heart disease (CHD) mortality by about 20%. This study validated CHD death classifications using Atherosclerosis Risk in Communities Study data.

Area of Science:

  • Epidemiology
  • Public Health
  • Cardiovascular Disease Research

Background:

  • Accurate mortality data is crucial for public health surveillance.
  • The validity of death certificates for specific causes, like coronary heart disease (CHD), requires ongoing evaluation.

Purpose of the Study:

  • To assess the accuracy of death certificates in identifying coronary heart disease (CHD) deaths.
  • To quantify the overestimation or underestimation of CHD mortality by death certificates.

Main Methods:

  • Utilized data from the Atherosclerosis Risk in Communities Study (ARIC) surveillance component.
  • Compared death certificate cause of death (ICD-9 codes 410-414, 429.2) with validated causes determined by physician review.
  • Gathered validation data through interviews, questionnaires, and medical record abstraction over 9 years.

Main Results:

  • The positive predictive value of death certificates for CHD was 0.67 (95% CI 0.66-0.68).
  • Sensitivity for identifying CHD deaths was 0.81 (95% CI 0.79-0.83), with a false-positive rate of 0.28 (95% CI 0.26-0.30).
  • Death certificates overestimated CHD mortality by approximately 20% in the ARIC communities.

Conclusions:

  • Death certificates tend to overestimate coronary heart disease mortality.
  • Overestimation varied by age, but was consistent over time and across genders.
  • Significant community-level variation in death certificate accuracy for CHD was observed.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...